GO:0097552 mitochondrial double-strand break repair via homologous recombination: DNA Repair Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0097552 describes the repair of double-strand breaks in mitochondrial DNA using homologous sequences, a process distinct from nuclear homologous recombination.
• Mitochondrial DNA repair pathways, including homologous recombination, are essential for maintaining mitochondrial genome stability and cellular function.
• Defects in mitochondrial double-strand break repair via homologous recombination are implicated in cancer, neurodegeneration, and aging.
• Key proteins involved include those in the homologous recombination machinery, such as RAD51, BRCA1, BRCA2, and mitochondrial-specific factors like POLG and TFAM.
• Experimental models for studying this process include knockout cell lines, point mutations, and knock-in reporters, often generated using CRISPR/Cas9.
• Understanding this pathway offers therapeutic opportunities, as inhibiting homologous recombination can sensitize cancer cells to radiation and chemotherapy.
Description
Mitochondrial double-strand break repair via homologous recombination (GO:0097552) is a biological process that repairs double-strand breaks in mitochondrial DNA using homologous sequences. Mitochondria are vital organelles that generate energy and regulate apoptosis, and their genome stability is crucial for cellular health. Unlike nuclear DNA, mitochondrial DNA is constantly exposed to reactive oxygen species and lacks protective histones, making efficient repair mechanisms essential. This process is distinct from nuclear homologous recombination and involves a unique set of proteins that localize to mitochondria. Research into this pathway has gained momentum due to its implications in cancer, neurodegenerative diseases, and aging. Understanding the molecular players and regulatory mechanisms of mitochondrial double-strand break repair via homologous recombination can inform the development of targeted therapies and diagnostic tools.
mitochondrial double-strand break repair via homologous recombination At A Glance
| GO ID | GO:0097552 |
|---|---|
| GO term | mitochondrial double-strand break repair via homologous recombination |
| Ontology | biological_process |
| Synonym | mtDSB repair via homologous recombination |
| Major function | Repair of double-strand breaks in mitochondrial DNA using homologous sequences |
| Related pathways | Homologous recombination, DNA damage response, mitochondrial genome maintenance |
| Cellular location | Mitochondria |
| Key proteins | RAD51, BRCA1, BRCA2, POLG, TFAM, and other homologous recombination factors |
What Is GO:0097552?
GO:0097552, mitochondrial double-strand break repair via homologous recombination, is defined as the repair of a double-strand break in mitochondrial DNA in which the broken DNA molecule is repaired using homologous sequences. This process ensures the maintenance of mitochondrial genome integrity and is carried out by proteins that are either mitochondrially targeted or shared with the nuclear homologous recombination machinery.
Why Is mitochondrial double-strand break repair via homologous recombination Important in Cell Biology?
Mitochondrial double-strand break repair via homologous recombination is critical for maintaining mitochondrial DNA integrity, which is essential for oxidative phosphorylation, cellular energy homeostasis, and apoptosis. Defects in this pathway can lead to mitochondrial dysfunction, which is associated with a wide range of human diseases, including cancer, neurodegeneration, and premature aging. Moreover, cancer cells often rely on homologous recombination for survival after DNA-damaging therapies, making this pathway a target for therapeutic intervention.
• Maintains mitochondrial genome stability and prevents mutations that can impair cellular respiration.
• Plays a role in cancer development and progression, as homologous recombination defects can lead to genomic instability.
• Influences sensitivity to radiation and chemotherapy, as inhibiting homologous recombination can enhance treatment efficacy.
• Implicated in neurodegenerative diseases where mitochondrial dysfunction is a hallmark.
• Contributes to aging processes through the accumulation of mitochondrial DNA damage.
• Provides potential targets for therapeutic intervention in cancers with homologous recombination deficiencies.
• Essential for mitochondrial DNA repair mechanisms beyond base excision repair.
• May be involved in the repair of double-strand breaks caused by environmental toxins such as TCDD.
What Happens During mitochondrial double-strand break repair via homologous recombination?
Detection of Double-Strand Breaks in Mitochondrial DNA
In simple terms: The cell first senses that mitochondrial DNA is broken.
Double-strand breaks in mitochondrial DNA can arise from reactive oxygen species, replication errors, or exogenous agents. The detection of these breaks involves proteins that recognize DNA damage and initiate the repair response. While the exact sensors in mitochondria are not fully characterized, evidence suggests that components of the nuclear DNA damage response, such as ATM and PARP, may also play a role in mitochondria.
Resection and Homologous Pairing
In simple terms: The broken DNA ends are processed to expose single-stranded tails that can find matching sequences.
Following detection, the broken DNA ends undergo resection to generate 3' single-stranded DNA overhangs. These overhangs are bound by recombinases such as RAD51, which facilitate the search for homologous sequences. In mitochondria, the homologous template may be a sister chromatid or repeated sequences within the mitochondrial genome.
Strand Invasion and DNA Synthesis
In simple terms: The single-stranded tail invades the matching DNA sequence and uses it as a template to copy the missing information.
The RAD51-coated single-stranded DNA invades the homologous duplex, forming a displacement loop (D-loop). DNA polymerase then extends the invading strand using the homologous sequence as a template. This step requires the coordinated action of multiple proteins, including those involved in nuclear homologous recombination, which may have mitochondrial isoforms or be recruited to mitochondria.
Resolution and Ligation
In simple terms: The repaired DNA is sealed and the structure is resolved to restore the original DNA sequence.
After DNA synthesis, the D-loop is resolved, and the newly synthesized DNA is ligated to the broken ends. This process may involve resolvases and ligases that are either mitochondrial-specific or shared with the nucleus. The outcome is a repaired mitochondrial DNA molecule that is identical to the original sequence, ensuring genome stability.
Regulation and Coordination with Mitochondrial Dynamics
In simple terms: The repair process is controlled and coordinated with mitochondrial fusion and fission.
Mitochondrial double-strand break repair via homologous recombination is regulated by factors that control mitochondrial dynamics, such as fusion and fission proteins. Additionally, post-translational modifications of repair proteins, such as phosphorylation by ATM, can modulate their activity. The pathway is also influenced by the metabolic state of the cell and the availability of nucleotides for DNA synthesis.
Key Genes Involved in GO:0097552 mitochondrial double-strand break repair via homologous recombination
The following genes and proteins are key players in mitochondrial double-strand break repair via homologous recombination, based on their established roles in DNA repair and mitochondrial biology.
| Gene | Major Role | Research Relevance |
|---|---|---|
| RAD51 | Recombinase that catalyzes strand invasion | Central to homologous recombination; target for cancer therapy |
| BRCA1 | Facilitates resection and RAD51 loading | Mutations linked to breast and ovarian cancer; involved in mitochondrial DNA repair |
| BRCA2 | Mediates RAD51 loading onto single-stranded DNA | Defects cause hereditary breast cancer; potential role in mitochondrial HR |
| POLG | Mitochondrial DNA polymerase | Mutations cause mitochondrial diseases; essential for DNA synthesis during repair |
| TFAM | Mitochondrial transcription factor A; packages mtDNA | Regulates mtDNA stability and repair; knockout models available |
| MRE11 | Part of MRN complex; involved in resection | Role in mitochondrial DNA repair is emerging |
| NBS1 | Part of MRN complex; recruits ATM | Mutations cause Nijmegen breakage syndrome; may affect mitochondrial repair |
| ATM | Kinase that coordinates DNA damage response | Activates repair proteins; also localizes to mitochondria |
| C1QBP | Multifunctional protein; involved in mitochondrial function | Inhibition impairs homologous recombination and mitochondrial function |
| LIG3 | DNA ligase involved in mitochondrial DNA repair | Essential for mitochondrial genome maintenance |
| PARP1 | Poly(ADP-ribose) polymerase; detects DNA breaks | Involved in mitochondrial DNA repair; PARP inhibitors in cancer therapy |
| FEN1 | Flap endonuclease; processes DNA intermediates | May play a role in mitochondrial HR resolution |
| EXO1 | Exonuclease involved in resection | Potential role in mitochondrial DNA end processing |
| BLM | RecQ helicase; resolves Holliday junctions | Mutations cause Bloom syndrome; may affect mitochondrial HR |
| RAD52 | Mediates single-strand annealing | Backup repair pathway; potential role in mitochondria |
| SLX4 | Scaffold for structure-specific nucleases | Involved in resolution of recombination intermediates |
How Is mitochondrial double-strand break repair via homologous recombination Regulated?
The regulation of mitochondrial double-strand break repair via homologous recombination is not fully understood, but it is likely controlled by both mitochondrial and nuclear factors. Post-translational modifications, such as phosphorylation by ATM, can influence the activity of repair proteins. Additionally, mitochondrial dynamics, including fusion and fission, can affect the availability of templates for homologous recombination. The pathway may also be regulated by the metabolic state of the cell, as nucleotide availability and redox balance impact DNA repair capacity.
mitochondrial double-strand break repair via homologous recombination and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| BRCA1 | Breast and ovarian cancer; homologous recombination deficiency | BRCA1 knockout cell lines; patient-derived xenografts |
| BRCA2 | Hereditary breast cancer; Fanconi anemia | BRCA2 knockout models; organoids |
| C1QBP | Triple-negative breast cancer; mitochondrial dysfunction | C1QBP knockout or inhibitor-treated cells |
| POLG | Mitochondrial diseases; progressive external ophthalmoplegia | POLG mutant knock-in mice; patient fibroblasts |
| ATM | Ataxia-telangiectasia; cancer predisposition | ATM knockout cell lines; mouse models |
Cancer
Defects in homologous recombination, including mitochondrial double-strand break repair, contribute to genomic instability and cancer predisposition. For example, inhibition of lipoylation suppresses homologous recombination and enhances radiation control of lung cancer. Similarly, a peptide inhibitor of C1QBP impairs mitochondrial function and suppresses homologous recombination in triple-negative breast cancer. These findings highlight the potential of targeting mitochondrial HR for cancer therapy.
Neurodegeneration
Mitochondrial dysfunction is a hallmark of neurodegenerative diseases such as Alzheimer's and Parkinson's. Impaired mitochondrial DNA repair, including homologous recombination, can lead to the accumulation of mutations and neuronal death. Understanding the role of mitochondrial HR in neurons may provide insights into disease mechanisms and therapeutic targets.
Aging
The accumulation of mitochondrial DNA damage is a contributing factor to aging. Efficient repair via homologous recombination is essential for maintaining mitochondrial genome integrity over time. Age-related decline in repair capacity may exacerbate mitochondrial dysfunction and accelerate aging phenotypes.
Mitochondrial Diseases
Mutations in genes involved in mitochondrial DNA maintenance, such as POLG, cause mitochondrial diseases characterized by neuromuscular and neurological symptoms. While the role of homologous recombination in these diseases is not fully defined, it is likely that defective repair contributes to pathogenesis.
From mitochondrial double-strand break repair via homologous recombination-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X directly repair mitochondrial double-strand breaks? | Knockout cell line (e.g., CRISPR/Cas9-mediated KO) |
| Does a specific mutation in gene X affect mitochondrial HR efficiency? | Point mutation knock-in cell line |
| Can a tagged version of gene X be used to track its localization during repair? | Tagged knock-in (e.g., GFP or HA tag) |
| Does overexpression of gene X enhance mitochondrial HR? | Overexpression cell line (e.g., lentiviral transduction) |
| What is the role of gene X in cancer cell response to radiation? | Knockout or knockdown in cancer cell lines followed by radiation |
| Can small molecules modulate mitochondrial HR? | Reporter cell lines with mitochondrial DSB inducible system |
How to Study the mitochondrial double-strand break repair via homologous recombination Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR knockout screen | Identification of genes required for mitochondrial HR | Discovering novel repair factors |
| HR reporter assay | Efficiency of homologous recombination | Quantifying repair capacity in different conditions |
| Proteomics (AP-MS) | Protein-protein interactions | Mapping the mitochondrial HR interactome |
| Immunofluorescence | Localization of repair proteins | Visualizing repair foci in mitochondria |
| Comet assay | DNA damage and repair | Measuring mitochondrial DNA breaks |
| qPCR-based mtDNA damage assay | Quantification of mitochondrial DNA lesions | Assessing repair kinetics |
| RNA-seq | Gene expression changes | Identifying pathways upregulated upon mitochondrial damage |
| CRISPR activation (CRISPRa) | Overexpression of candidate genes | Testing sufficiency of genes in mitochondrial HR |
CRISPR/Cas9 Knockout Screening
Genome-wide CRISPR knockout screens can identify genes essential for mitochondrial double-strand break repair via homologous recombination. Cells with inducible mitochondrial DNA damage are subjected to sgRNA libraries, and sgRNAs that confer resistance or sensitivity are identified by sequencing.
Reporter Assays for Mitochondrial HR
Fluorescent reporter systems can measure homologous recombination efficiency in mitochondria. These reporters typically consist of a disrupted fluorescent protein gene that can be restored by HR, allowing quantification of repair events.
Proteomics and Interactomics
Mass spectrometry-based proteomics can identify proteins that associate with mitochondrial DNA repair complexes. Immunoprecipitation of tagged repair proteins followed by LC-MS/MS reveals interaction partners and post-translational modifications.
Imaging of Mitochondrial DNA Repair Foci
Fluorescence microscopy can visualize the recruitment of repair proteins to mitochondrial DNA lesions. Using fluorescently tagged proteins and mitochondrial markers, researchers can track the spatiotemporal dynamics of repair.
How CRISPR Can Be Used to Study GO:0097552 mitochondrial double-strand break repair via homologous recombination
Knockout
CRISPR/Cas9-mediated knockout of genes such as RAD51, BRCA1, or POLG can abolish mitochondrial double-strand break repair via homologous recombination, leading to mitochondrial DNA instability. These models are valuable for studying the consequences of repair deficiency and for drug screening.
Point Mutation
Introducing specific point mutations in genes like POLG or ATM using CRISPR base editing or HDR can mimic disease-associated variants and reveal their impact on mitochondrial HR. Such models help dissect the functional domains required for repair.
Knock-in
Knock-in of tagged versions of repair proteins (e.g., GFP-RAD51) allows real-time tracking of their recruitment to mitochondrial DNA breaks. This approach provides insights into the dynamics and stoichiometry of the repair machinery.
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression can elevate levels of repair proteins to test whether they enhance mitochondrial HR capacity. Overexpression models are useful for identifying rate-limiting factors and for therapeutic applications.
How EDITGENE Supports mitochondrial double-strand break repair via homologous recombination Research
Researchers studying mitochondrial double-strand break repair via homologous recombination-related genes often need to determine whether a candidate gene is causally involved in the repair process or merely correlated with it. EDITGENE provides a comprehensive suite of CRISPR-based services to generate precisely engineered cell models, enabling functional validation of genes in this pathway.
Contact EDITGENE today to design your custom CRISPR model for mitochondrial double-strand break repair via homologous recombination research.
Frequently Asked Questions About mitochondrial double-strand break repair via homologous recombination
What is mitochondrial double-strand break repair via homologous recombination?
It is a biological process (GO:0097552) that repairs double-strand breaks in mitochondrial DNA using homologous sequences, ensuring mitochondrial genome stability.
What genes are involved in mitochondrial double-strand break repair via homologous recombination?
Key genes include RAD51, BRCA1, BRCA2, POLG, TFAM, and others involved in homologous recombination and mitochondrial DNA maintenance.
Why is mitochondrial double-strand break repair via homologous recombination important?
It maintains mitochondrial DNA integrity, which is crucial for energy production and cell survival; defects are linked to cancer, neurodegeneration, and aging.
How is mitochondrial double-strand break repair via homologous recombination studied?
Researchers use CRISPR knockout screens, HR reporter assays, proteomics, and imaging to study this pathway.
What diseases are associated with defects in mitochondrial double-strand break repair via homologous recombination?
Cancers such as breast and lung cancer, neurodegenerative diseases, and mitochondrial disorders.
Can mitochondrial double-strand break repair via homologous recombination be targeted for cancer therapy?
Yes, inhibiting this pathway can sensitize cancer cells to radiation and chemotherapy, as shown in lung and breast cancer models.
What is the role of RAD51 in mitochondrial double-strand break repair via homologous recombination?
RAD51 is a recombinase that catalyzes strand invasion during homologous recombination, essential for the repair process.
How does mitochondrial DNA repair differ from nuclear DNA repair?
Mitochondrial DNA repair relies on a distinct set of proteins and occurs in the mitochondrial matrix, though some factors are shared with the nucleus.
What experimental models are available for studying mitochondrial double-strand break repair via homologous recombination?
Knockout, point mutation, knock-in, and overexpression cell lines generated via CRISPR/Cas9 are commonly used.
What services does EDITGENE offer for mitochondrial double-strand break repair via homologous recombination research?
EDITGENE provides CRISPR knockout, point mutation, knock-in, overexpression, library screening, and bioinformatics services to support functional studies.
Conclusion
Mitochondrial double-strand break repair via homologous recombination (GO:0097552) is a vital process for maintaining mitochondrial genome stability and cellular health. Its dysfunction is implicated in cancer, neurodegeneration, and aging, making it a promising target for therapeutic intervention. Advances in CRISPR-based tools and screening technologies are accelerating our understanding of this pathway and its components. EDITGENE is committed to providing researchers with the engineered cell models and bioinformatics support needed to unravel the complexities of mitochondrial HR and translate findings into clinical applications.
References
- 1. Chiang JC et al.. 2025. Lipoylation inhibition enhances radiation control of lung cancer by suppressing homologous recombination DNA damage repair.. Sci Adv 11(11):eadt1241 PMID: 40073141
- 2. Wahyuni EA et al.. 2022. Selenocystine induces oxidative-mediated DNA damage via impairing homologous recombination repair of DNA double-strand breaks in human hepatoma cells.. Chem Biol Interact 365:110046 PMID: 35863474
- 3. Kaniak-Golik A et al.. 2015. Mitochondria-nucleus network for genome stability.. Free Radic Biol Med 82:73-104 PMID: 25640729
- 4. Hazkani-Covo E et al.. 2008. Numt-mediated double-strand break repair mitigates deletions during primate genome evolution.. PLoS Genet 4(10):e1000237 PMID: 18949041
- 5. Croteau DL et al.. 1999. Mitochondrial DNA repair pathways.. Mutat Res 434(3):137-48 PMID: 10486588
- 6. Allkanjari K et al.. 2021. Beyond base excision repair: an evolving picture of mitochondrial DNA repair.. Biosci Rep 41(10) PMID: 34608928
- 7. Li X et al.. 2025. A new peptide inhibitor of C1QBP exhibits potent anti-tumour activity against triple negative breast cancer by impairing mitochondrial function and suppressing homologous recombination repair.. Clin Transl Med 15(1):e70162 PMID: 39748215
- 8. Chan CY et al.. 2004. TCDD affects DNA double strand-break repair.. Toxicol Sci 81(1):133-8 PMID: 15201442
